Studies have shown that CXCL9, CXCI 10, and CXCL11 are involved in the immune dysfunction of target organs and over-amplification of local inflammatory responses at lesion sites in many autoimmune diseases, including IBD [53, 54]. Here, CXCL11 is linked to inflammatory bowel disease.